233 related articles for article (PubMed ID: 29416026)
1. Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner.
Wang YQ; Wang HL; Xu J; Tan J; Fu LN; Wang JL; Zou TH; Sun DF; Gao QY; Chen YX; Fang JY
Nat Commun; 2018 Feb; 9(1):545. PubMed ID: 29416026
[TBL] [Abstract][Full Text] [Related]
2. SIRT5-mediated ME2 desuccinylation promotes cancer growth by enhancing mitochondrial respiration.
Teng P; Cui K; Yao S; Fei B; Ling F; Li C; Huang Z
Cell Death Differ; 2024 Jan; 31(1):65-77. PubMed ID: 38007551
[TBL] [Abstract][Full Text] [Related]
3. Set7/9 aggravates ischemic brain injury via enhancing glutamine metabolism in a blocking Sirt5 manner.
Wang J; Tan S; Zhang Y; Xu J; Li Y; Cheng Q; Ding C; Liu X; Chang J
Cell Death Differ; 2024 Apr; 31(4):511-523. PubMed ID: 38365969
[TBL] [Abstract][Full Text] [Related]
4. PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.
Li Y; Li X; Li X; Zhong Y; Ji Y; Yu D; Zhang M; Wen JG; Zhang H; Goscinski MA; Nesland JM; Suo Z
Oncotarget; 2016 Aug; 7(33):53837-53852. PubMed ID: 27462778
[TBL] [Abstract][Full Text] [Related]
5. SIRT5 promote malignant advancement of chordoma by regulating the desuccinylation of c-myc.
Jiang M; Huang Z; Chen L; Deng T; Liu J; Wu Y
BMC Cancer; 2024 Mar; 24(1):386. PubMed ID: 38532359
[TBL] [Abstract][Full Text] [Related]
6. Functional synergy of a human-specific and an ape-specific metabolic regulator in human neocortex development.
Xing L; Gkini V; Nieminen AI; Zhou HC; Aquilino M; Naumann R; Reppe K; Tanaka K; Carmeliet P; Heikinheimo O; Pääbo S; Huttner WB; Namba T
Nat Commun; 2024 Apr; 15(1):3468. PubMed ID: 38658571
[TBL] [Abstract][Full Text] [Related]
7. LC-MS/MS-based quantitative study of the acyl group- and site-selectivity of human sirtuins to acylated nucleosomes.
Tanabe K; Liu J; Kato D; Kurumizaka H; Yamatsugu K; Kanai M; Kawashima SA
Sci Rep; 2018 Feb; 8(1):2656. PubMed ID: 29422688
[TBL] [Abstract][Full Text] [Related]
8. SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis.
Greene KS; Lukey MJ; Wang X; Blank B; Druso JE; Lin MJ; Stalnecker CA; Zhang C; Negrón Abril Y; Erickson JW; Wilson KF; Lin H; Weiss RS; Cerione RA
Proc Natl Acad Sci U S A; 2019 Dec; 116(52):26625-26632. PubMed ID: 31843902
[TBL] [Abstract][Full Text] [Related]
9. Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.
Maeda H; Khatami M
Clin Transl Med; 2018 Mar; 7(1):11. PubMed ID: 29541939
[TBL] [Abstract][Full Text] [Related]
10. Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.
Kumar S; Lombard DB
Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):311-334. PubMed ID: 29637793
[TBL] [Abstract][Full Text] [Related]
11. The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications.
Carrico C; Meyer JG; He W; Gibson BW; Verdin E
Cell Metab; 2018 Mar; 27(3):497-512. PubMed ID: 29514063
[TBL] [Abstract][Full Text] [Related]
12. Regulation of UCP1 and Mitochondrial Metabolism in Brown Adipose Tissue by Reversible Succinylation.
Wang G; Meyer JG; Cai W; Softic S; Li ME; Verdin E; Newgard C; Schilling B; Kahn CR
Mol Cell; 2019 May; 74(4):844-857.e7. PubMed ID: 31000437
[TBL] [Abstract][Full Text] [Related]
13. Glutamate dehydrogenase (GLUD1) expression in breast cancer.
Craze ML; El-Ansari R; Aleskandarany MA; Cheng KW; Alfarsi L; Masisi B; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Feb; 174(1):79-91. PubMed ID: 30470977
[TBL] [Abstract][Full Text] [Related]
14. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer.
Chen XF; Tian MX; Sun RQ; Zhang ML; Zhou LS; Jin L; Chen LL; Zhou WJ; Duan KL; Chen YJ; Gao C; Cheng ZL; Wang F; Zhang JY; Sun YP; Yu HX; Zhao YZ; Yang Y; Liu WR; Shi YH; Xiong Y; Guan KL; Ye D
EMBO Rep; 2018 May; 19(5):. PubMed ID: 29491006
[TBL] [Abstract][Full Text] [Related]
15. SIRT5 impairs aggregation and activation of the signaling adaptor MAVS through catalyzing lysine desuccinylation.
Liu X; Zhu C; Zha H; Tang J; Rong F; Chen X; Fan S; Xu C; Du J; Zhu J; Wang J; Ouyang G; Yu G; Cai X; Chen Z; Xiao W
EMBO J; 2020 Jun; 39(11):e103285. PubMed ID: 32301534
[TBL] [Abstract][Full Text] [Related]
16. SIRT5 deficiency enhances the proliferative and therapeutic capacities of adipose-derived mesenchymal stem cells via metabolic switching.
Ou T; Yang W; Li W; Lu Y; Dong Z; Zhu H; Sun X; Dong Z; Weng X; Chang S; Li H; Li Y; Qiu Z; Hu K; Sun A; Ge J
Clin Transl Med; 2020 Sep; 10(5):e172. PubMed ID: 32997407
[TBL] [Abstract][Full Text] [Related]
17. α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development.
Wang X; Liu R; Qu X; Yu H; Chu H; Zhang Y; Zhu W; Wu X; Gao H; Tao B; Li W; Liang J; Li G; Yang W
Mol Cell; 2019 Oct; 76(1):148-162.e7. PubMed ID: 31447391
[TBL] [Abstract][Full Text] [Related]
18. SIRT5 Promotes Hepatocellular Carcinoma Progression by Regulating Mitochondrial Apoptosis.
Zhang R; Wang C; Tian Y; Yao Y; Mao J; Wang H; Li Z; Xu Y; Ye M; Wang L
J Cancer; 2019; 10(16):3871-3882. PubMed ID: 31333804
[TBL] [Abstract][Full Text] [Related]
19. Desuccinylation-Triggered Peptide Self-Assembly: Live Cell Imaging of SIRT5 Activity and Mitochondrial Activity Modulation.
Yang L; Peltier R; Zhang M; Song D; Huang H; Chen G; Chen Y; Zhou F; Hao Q; Bian L; He ML; Wang Z; Hu Y; Sun H
J Am Chem Soc; 2020 Oct; 142(42):18150-18159. PubMed ID: 32991157
[TBL] [Abstract][Full Text] [Related]
20.
Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
